EDIT Competitors & Alternatives
Compare Editas Medicine Inc with similar stocks in the same industry
Biotechnology
EDIT
Main Stock$2.80
Tradestie Score
49
Market Cap
$319.22M
Revenue Growth
-0.4%
Analyst Upside
+106.4%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GLUE
Monte Rosa Therapeutics, Inc. Common Stock
|
$18.67
|
$463.20M | - | 58 | Compare |
|
SLDB
Solid Biosciences Inc. Common Stock
|
$8.30
|
$457.09M | - | 64 | Compare |
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$5.25
|
$454.29M | - | 58 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$22.16
|
$448.32M | - | 67 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$24.60
|
$422.50M | - | 57 | Compare |
|
PACB
Pacific Biosciences of California, Inc.
|
$1.32
|
$414.51M | - | 49 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$63.49
|
$410.79M | - | 51 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$10.42
|
$407.71M | - | 61 | Compare |
More EDIT Analysis
Data updated: Jun 22, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry